findmyKOL
Clinical trialNCT02307201CompletedPhase 2/PHASE3Interventional

Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia

SponsorComplejo Hospitalario Dr. Arnulfo Arias MadridEnrollment1,114Post Partum Severe Preeclampsia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

There is no evidence that patients receiving magnesium sulfate before birth are required to maintain the drug for 24 hours. Therefore the investigators will have a randomized clinical study in patients with severe preeclampsia who have been treated with impregnation of magnesium sulphate and at least eight hours have received the drug before birth. If the patient agrees and signs the consent is randomized to: 1-receive sulfate for 24 hours postpartum as usual or, 2- not receiving the postpartum magnesium sulfate or other anticonvulsant drugs. This study can be conducted in 12 maternity latin america.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jack Ludmir, MD

    School of medicine, Pennsylvania Hospital. University de Pennsylvania. Philadelphia

    Study Chair
    clinicaltrials.gov ↗
  • Paulino Vigil De Gracia

    Complejo Hospitalario Dr. Arnulfo Arias Madrid

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Dominican Republic
  • Hospital Materno Infantil San Lorezo de Las Minas

    Santo Domingo, Santo Domingo Province, Dominican Republic

  • Hospital Universitario Maternidad Nuestra Señoa de Alta Gracia

    Santo Domingo, Santo Domingo Province, Dominican Republic

Ecuador
  • Hospital Teodoro Maldonado de Guayaquil

    Guayaquil, Ecuador

El Salvador
  • Hospital Primero de Mayo

    San Salvador, El Salvador

Panama
  • Hospital Jose Domingo de Obaldia

    Chiriquí, Chiriquí Province, Panama

  • Complejo Hospitalario Caja de Seguro Social

    Panama City, Provincia de Panamá, Panama

  • Hospital Santo Tomás

    Panama City, Provincia de Panamá, Panama

Peru
  • Hospital Regional de Cojamarca, Perú,

    Cajamarca, Cajamarca Department, Peru

  • Instituto Materno Perinatal, Maternidad de Lima

    Lima, Lima Province, Peru

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Magnesium sulfate →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2014
Primary completion
31 Dec 2015
Completion
31 Dec 2015
Last update posted
1 Feb 2017
Registered enrollment
1,114
Registry id
NCT02307201
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.